COMMUNIQUÉS West-GlobeNewswire

Affimed Reports Second Quarter 2019 Financial and Operational Results
07/08/2019
Heidelberg, Germany, August 7, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today reported financial and [...]
Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Jeffrey Stein, Ph.D., [...]
Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update
07/08/2019
Phase 2 cystic fibrosis clinical trial IND is open in the U.S., protocol endorsed by the Cystic Fibrosis Foundation (CFF) Initiated a Phase 2 clinical trial for ELX-02 in cystinosis in Canada and received non-dilutive [...]
Allogene Therapeutics Reports Second Quarter 2019 Financial Results
07/08/2019
ALLO-501 Phase 1 ALPHA Trial in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL) Advances with Five Clinical Trial Sites Open Investigational New Drug (IND) Application Cleared by the U.S. Food & Drug [...]
CURE Pharmaceutical Expands Board with Two Women Directors
07/08/2019
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board, Dr. Lauren Chung, Ph.D [...]
Indus Holdings, Inc. to Report Second Quarter 2019 Financial Results on August 21, 2019
07/08/2019
SALINAS, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that it plans to release its financial results for the [...]
Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer
07/08/2019
SALT LAKE CITY, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced that the AstraZeneca/Merck Phase III PROfound [...]
Intercept Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
Company delivers strongest quarter to date with worldwide Ocaliva ® net sales of $65.9 million in the second quarter of 2019, representing 53% growth versus the prior year quarter U.S. NDA filing for NASH on track for [...]
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
07/08/2019
-- Both studies met primary and all key secondary endpoints with statistically significant and clinically meaningful results in reductions of weight and hunger -- -- Rhythm on track to complete rolling NDA submission to [...]
AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 14, 2019
07/08/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
ProQR Announces Financial Results for the Second Quarter of 2019
07/08/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Trevena Reports Second Quarter 2019 Results
07/08/2019
— Enrollment for healthy volunteer QT study ongoing, topline data on schedule for Q4 2019 readout — — Company remains on track to resubmit NDA for oliceridine in Q1 2020 — — Cash runway as of June 30, 2019 continues to [...]
Natus Expands the Supporting Community of Otoscan
07/08/2019
Natus to continue their successful pilot program with Starkey Hearing Technologies PLEASANTON, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading [...]
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates
07/08/2019
Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing [...]
Surgery Partners, Inc. Announces Second Quarter 2019 Results
07/08/2019
BRENTWOOD, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter [...]
Arcturus to Report Corporate Overview and Financial Results on August 15
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics [...]
AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and removing milestone revenue Vyleesi on-track for national [...]
Arvinas To Present at the Wedbush PacGrow Healthcare Conference
07/08/2019
NEW HAVEN, Conn. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that the company is [...]
YSS Corp. Announces Receipt of Retail Cannabis Store License in Edmonton
07/08/2019
CALGARY, Alberta, Aug. 07, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce receipt of an additional cannabis retail license from the Alberta Gaming, [...]

Pages